Squarepoint’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.78M | Buy |
119,978
+46,711
| +64% | +$1.47M | ﹤0.01% | 902 |
|
2025
Q1 | $2.4M | Buy |
73,267
+52,775
| +258% | +$1.73M | ﹤0.01% | 1079 |
|
2024
Q4 | $741K | Sell |
20,492
-475
| -2% | -$17.2K | ﹤0.01% | 1711 |
|
2024
Q3 | $654K | Buy |
+20,967
| New | +$654K | ﹤0.01% | 1638 |
|
2023
Q4 | – | Sell |
-14,551
| Closed | -$401K | – | 2952 |
|
2023
Q3 | $401K | Sell |
14,551
-1,104
| -7% | -$30.4K | ﹤0.01% | 1750 |
|
2023
Q2 | $471K | Buy |
15,655
+3,199
| +26% | +$96.2K | ﹤0.01% | 1622 |
|
2023
Q1 | $451K | Sell |
12,456
-19,888
| -61% | -$721K | ﹤0.01% | 1513 |
|
2022
Q4 | $1.15M | Sell |
32,344
-8,498
| -21% | -$303K | ﹤0.01% | 1033 |
|
2022
Q3 | $1.38M | Buy |
+40,842
| New | +$1.38M | 0.01% | 939 |
|
2022
Q2 | – | Sell |
-13,785
| Closed | -$446K | – | 2614 |
|
2022
Q1 | $446K | Sell |
13,785
-20,307
| -60% | -$657K | ﹤0.01% | 1547 |
|
2021
Q4 | $994K | Buy |
+34,092
| New | +$994K | ﹤0.01% | 1223 |
|
2021
Q2 | – | Sell |
-22,764
| Closed | -$596K | – | 3015 |
|
2021
Q1 | $596K | Buy |
22,764
+8,709
| +62% | +$228K | ﹤0.01% | 1411 |
|
2020
Q4 | $354K | Sell |
14,055
-23,132
| -62% | -$583K | ﹤0.01% | 1748 |
|
2020
Q3 | $775K | Sell |
37,187
-24,544
| -40% | -$512K | 0.01% | 1077 |
|
2020
Q2 | $1.47M | Buy |
61,731
+1,623
| +3% | +$38.5K | 0.02% | 750 |
|
2020
Q1 | $1.08M | Sell |
60,108
-28,923
| -32% | -$520K | 0.03% | 687 |
|
2019
Q4 | $2.11M | Buy |
89,031
+39,579
| +80% | +$939K | 0.01% | 853 |
|
2019
Q3 | $1.36M | Buy |
49,452
+37,928
| +329% | +$1.04M | 0.01% | 1000 |
|
2019
Q2 | $381K | Sell |
11,524
-50,621
| -81% | -$1.67M | ﹤0.01% | 1770 |
|
2019
Q1 | $2.18M | Buy |
62,145
+43,843
| +240% | +$1.54M | 0.02% | 738 |
|
2018
Q4 | $608K | Buy |
18,302
+866
| +5% | +$28.8K | 0.01% | 1139 |
|
2018
Q3 | $878K | Buy |
+17,436
| New | +$878K | 0.01% | 1052 |
|
2018
Q2 | – | Sell |
-56,569
| Closed | -$2.59M | – | 2031 |
|
2018
Q1 | $2.59M | Buy |
56,569
+47,122
| +499% | +$2.16M | 0.04% | 486 |
|
2017
Q4 | $376K | Sell |
9,447
-42,729
| -82% | -$1.7M | 0.01% | 1354 |
|
2017
Q3 | $2.09M | Buy |
52,176
+5,869
| +13% | +$235K | 0.04% | 478 |
|
2017
Q2 | $2M | Buy |
46,307
+3,156
| +7% | +$136K | 0.04% | 512 |
|
2017
Q1 | $1.35M | Buy |
43,151
+10,065
| +30% | +$315K | 0.04% | 492 |
|
2016
Q4 | $835K | Buy |
+33,086
| New | +$835K | 0.03% | 577 |
|
2016
Q3 | – | Sell |
-11,861
| Closed | -$242K | – | 1246 |
|
2016
Q2 | $242K | Sell |
11,861
-13,133
| -53% | -$268K | 0.02% | 824 |
|
2016
Q1 | $381K | Sell |
24,994
-3,500
| -12% | -$53.4K | 0.03% | 731 |
|
2015
Q4 | $383K | Buy |
+28,494
| New | +$383K | 0.04% | 678 |
|